한글목차

세계 눈물 삼투압 측정 시스템 시장은 병원 및 안과 클리닉 시장에서의 기회를 배경으로 미래가 기대되는 시장입니다. 이 시장은 2025-2031년 연평균 복합 성장률(CAGR) 15%를 보일 것으로 예측됩니다. 주요 성장 요인으로는 안구건조증 유병률 증가, 정확한 진단 도구에 대한 수요 증가, 안구 건강 관리에 대한 인식 증가 등을 꼽을 수 있습니다.

• Lucintel의 예측에 따르면, 유형별로는 핸드헬드형이 예측 기간 동안 높은 성장률을 보일 것으로 예측됩니다.
• 용도별로는 안과용이 더 높은 성장률을 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예측됩니다.

눈물 삼투압 측정 시스템 시장의 새로운 트렌드

눈물 삼투압 측정 시스템 시장은 진단 정확도, 환자 편의성, 데이터 관리 향상에 초점을 맞춘 새로운 트렌드로 인해 큰 변화를 겪고 있습니다. 이러한 추세는 기본적인 측정을 넘어 안구건조증 진단과 치료에 대한 보다 정교하고 통합적이며 개별화된 접근 방식을 만들어내고 있습니다. 시장은 원활한 기술과 환자 중심의 디자인을 더 중요시하는 방향으로 진화하고 있습니다.

• 휴대성과 핸드헬드 디바이스: 이러한 추세는 소형 배터리 구동식 핸드헬드 눈물 삼투압 측정 시스템의 개발을 수반합니다. 목적은 검사를 전문 검사실에서 진료 현장(의사의 진료소, 이동진료소 등)으로 전환하는 것입니다. 이를 통해 접근성과 편의성이 크게 향상됩니다. 신속한 현장 진단이 가능해져 환자와 결과 및 치료 옵션에 대해 즉각적으로 대화할 수 있습니다.
• 전자의무기록과의 연계: 검사 결과를 환자의 전자의무기록(EHR)에 직접 무선으로 전송할 수 있는 시스템 개발에 대한 관심이 높아지고 있습니다. 이를 통해 수동 데이터 입력이 불필요해져 인위적인 실수의 위험을 줄일 수 있습니다. 임상 워크플로우를 효율화하고 간소화하며, 객관적인 데이터를 환자 기록에 영구적으로 저장하여 장기적인 모니터링과 맞춤 치료 계획을 수립할 수 있도록 돕습니다.
• 원격의료와 원격 모니터링: 이 트렌드는 원격으로 눈물 삼투압 측정과 데이터 공유를 가능하게 하는 시스템 구축을 목표로 하고 있습니다. 아직 보급이 많이 진행되지는 않았지만, 환자가 집에서 검사를 하고 데이터를 의사에게 전송할 수 있는 개념입니다. 이를 통해 진료소를 넘어선 진료의 대폭적인 확장을 실현할 수 있습니다. 이 기술을 통해 만성 안구건조증 환자의 모니터링 빈도를 높여 증상 관리 개선 및 내원 횟수 감소를 기대할 수 있습니다.
• 일회용 및 일회용 센서 : 이 추세는 일회용 일회용 마이크로플루이딕스 센서 또는 테스트 카드의 개발에 초점을 맞추었습니다. 이 센서는 한 번 사용 후 폐기하도록 설계되어 무균성을 보장하고 복잡한 세척 절차가 필요하지 않습니다. 이를 통해 환자의 안전과 편의성을 향상시킬 수 있습니다. 이 설계는 교차 오염의 위험을 크게 줄이고 의료 종사자의 검사 과정을 간소화합니다.
• 멀티 바이오마커 진단 플랫폼: 이러한 추세는 눈물 삼투압뿐만 아니라 MMP-9와 같은 염증 마커를 포함한 안구건조증 주요 바이오마커를 측정할 수 있는 통합 시스템 개발을 의미합니다. 이를 통해 보다 종합적인 진단을 얻을 수 있습니다. 임상의는 환자의 상태를 보다 완벽하게 이해할 수 있고, 보다 효과적인 치료 전략을 수립할 수 있습니다.

이러한 추세는 눈물 삼투압 측정 시스템을 전문적인 진단 도구에서 일상적인 안과 진료의 통합적이고 효율적인 데이터 기반 구성 요소로 전환하는 등 시장을 재편하고 있습니다. 진단 정확도, 사용자 편의성, 그리고 임상 워크플로우에 대한 기술의 원활한 통합을 우선시하는 종합적인 접근 방식으로 초점을 옮기고 있습니다.

눈물 삼투압 측정 시스템 시장의 최근 동향

눈물 삼투압 측정 시스템 시장은 제품 디자인, 기능성, 시장 전개에 큰 영향을 미치는 최근 트렌드에 따라 변혁을 겪고 있습니다. 이러한 발전은 기술 혁신, 환자 니즈의 진화, 객관적인 진단 도구에 대한 강조가 결합되어 추진되고 있습니다. 이러한 발전으로 시스템의 효율성, 접근성, 사용자 편의성이 향상되고 있습니다.

• 휴대용 및 휴대용 장치 도입: 소형화된 휴대용 눈물 삼투압 측정 시스템의 상업적 출시는 주요한 발전입니다. 이를 통해 소규모 안과 병원을 포함한 보다 광범위한 임상 현장에서 검사 수행이 가능해졌습니다. 이 진단 도구의 접근성이 크게 향상되어 전문 클리닉에서 진료 현장(Point of Care)으로의 보급이 진행되고 있습니다.
• 마이크로플루이딕스 기술의 발전: 최근 마이크로플루이딕스 기술의 발전으로 극소량(100나노리터 미만)의 눈물액 샘플을 채취하고 분석할 수 있게 되었습니다. 이를 통해 검사의 침습성을 줄이고 환자의 부담을 줄일 수 있습니다. 이러한 영향은 환자 경험을 크게 개선하고 진단 검사의 보급을 촉진하는 데 매우 중요합니다.
• 새로운 시스템의 FDA 승인: 미국 시장에서는 새로운 눈물 삼투압 측정 시스템에 대한 FDA 승인이 잇따르고 있습니다. 이 규제 당국의 승인은 의료 서비스 제공업체에게 신뢰성과 안전성에 대한 강력한 보증이 될 것입니다. 이를 통해 시장 도입이 가속화되고, 안과 의사와 검안사들 사이에서 이 장치의 임상적 유용성에 대한 확신이 높아지고 있습니다.
• 임피던스 분광법 채택: 많은 새로운 시스템은 눈물 삼투압 측정에 임피던스 분광법을 채택하고 있습니다. 이 방법은 정확하고 빠른 결과를 제공합니다. 이를 통해 보다 안정적이고 효율적인 진단 프로세스를 실현할 수 있습니다. 이러한 시스템에서 얻은 정량적이고 객관적인 데이터는 기존의 안구건조증 검사에 종종 수반되는 주관성을 제거하는 데 도움이 됩니다.
• 전략적 제휴 및 인수: 시장에서는 대형 의료기기 업체들이 소규모의 혁신적인 스타트업 기업들과 전략적 제휴를 맺거나 인수하는 추세를 볼 수 있습니다. 이 통합을 통해 시장 리더는 새로운 기술을 신속하게 통합하고 제품 포트폴리오를 확장할 수 있습니다. 이로 인해 혁신적인 제품 시장 출시가 가속화되고, 경쟁 구도가 더욱 집중화, 심화되고 있습니다.

이러한 발전은 종합적으로 안구건조증 진단에 있어 환자 중심적이고 기술 중심의 접근 방식으로의 전환을 촉진함으로써 시장에 영향을 미치고 있습니다. 진단 데이터의 품질을 향상시킬 뿐만 아니라, 프로세스를 보다 편리하고 접근하기 쉬우며, 현대의 임상 실습에 통합될 수 있는 프로세스로 전환하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 눈물 삼투압 측정 시스템 시장 : 유형별

• 매력 분석 : 유형별
• 핸드헬드 형
• 탁상형

제5장 세계의 눈물 삼투압 측정 시스템 시장 : 용도별

• 매력 분석 : 용도별
• 병원
• 안과 클리닉
• 기타

제6장 지역 분석

제7장 북미의 눈물 삼투압 측정 시스템 시장

• 북미 눈물 삼투압 측정 시스템 시장 : 유형별
• 북미 눈물 삼투압 측정 시스템 시장 : 용도별
• 미국 눈물 삼투압 측정 시스템 시장
• 멕시코 눈물 삼투압 측정 시스템 시장
• 캐나다 눈물 삼투압 측정 시스템 시장

제8장 유럽의 눈물 삼투압 측정 시스템 시장

• 유럽 눈물 삼투압 측정 시스템 시장 : 유형별
• 유럽 눈물 삼투압 측정 시스템 시장 : 용도별
• 독일 눈물 삼투압 측정 시스템 시장
• 프랑스 눈물 삼투압 측정 시스템 시장
• 스페인 눈물 삼투압 측정 시스템 시장
• 이탈리아 눈물 삼투압 측정 시스템 시장
• 영국 눈물 삼투압 측정 시스템 시장

제9장 아시아태평양의 눈물 삼투압 측정 시스템 시장

• 아시아태평양 눈물 삼투압 측정 시스템 시장 : 유형별
• 아시아태평양 눈물 삼투압 측정 시스템 시장 : 용도별
• 일본 눈물 삼투압 측정 시스템 시장
• 인도 눈물 삼투압 측정 시스템 시장
• 중국 눈물 삼투압 측정 시스템 시장
• 한국 눈물 삼투압 측정 시스템 시장
• 인도네시아 눈물 삼투압 측정 시스템 시장

제10장 기타 지역(ROW)의 눈물 삼투압 측정 시스템 시장

• ROW 눈물 삼투압 측정 시스템 시장 : 유형별
• ROW 눈물 삼투압 측정 시스템 시장 : 용도별
• 중동 눈물 삼투압 측정 시스템 시장
• 남미 눈물 삼투압 측정 시스템 시장
• 아프리카 눈물 삼투압 측정 시스템 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계 눈물 삼투압 측정 시스템 시장의 새로운 동향
• 전략 분석

제13장 밸류체인 주요 기업 개요

• 경쟁 분석
• I-MED Pharma
• Trukera Medical
• TearLab Corporation
• AbbVie

제14장 부록

영문목차

The future of the global tear osmolarity system market looks promising with opportunities in the hospital and ophthalmology clinic markets. The global tear osmolarity system market is expected to grow with a CAGR of 15% from 2025 to 2031. The major drivers for this market are the increasing prevalence of dry eye diseases, the rising demand for accurate diagnostic tools, and the growing awareness about ocular health management.

• Lucintel forecasts that, within the type category, handheld is expected to witness higher growth over the forecast period.
• Within the application category, ophthalmology clinic is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Tear Osmolarity System Market

The tear osmolarity system market is undergoing a significant transformation with emerging trends focused on improving diagnostic accuracy, patient convenience, and data management. These trends are moving beyond basic measurements to create a more sophisticated, integrated, and personalized approach to dry eye diagnosis and treatment. The market is evolving with a greater emphasis on seamless technology and patient-centric design.

• Portability and Handheld Devices: This trend involves developing compact, battery-operated, handheld tear osmolarity systems. The goal is to move testing from specialized labs to the point of care, such as a doctor's office or even a mobile clinic. The impact is a significant increase in accessibility and convenience. This allows for quick, on-the-spot diagnoses, enabling immediate discussion of results and treatment options with patients.
• Integration with Electronic Health Records: There is a growing focus on developing systems that can wirelessly transmit test results directly to a patient's electronic health record (EHR). This eliminates manual data entry and reduces the risk of human error. The impact is a more streamlined and efficient clinical workflow. It ensures that objective data is a permanent part of the patient's record, enabling better long-term monitoring and personalized treatment plans.
• Telemedicine and Remote Monitoring: This trend involves creating systems that enable remote tear osmolarity testing and data sharing. While not yet widespread, the concept is to allow patients to test at home and send the data to their doctor. The impact is a significant expansion of care beyond the clinic. This technology could enable more frequent monitoring for patients with chronic dry eye, leading to better management of their condition and fewer in-person visits.
• Disposable and Single-Use Sensors: This trend focuses on developing single-use, disposable microfluidic sensors or test cards. These sensors are designed to be used once and then discarded, ensuring sterility and eliminating the need for complex cleaning procedures. The impact is enhanced patient safety and convenience. This design significantly reduces the risk of cross-contamination and simplifies the testing process for healthcare professionals.
• Multi-Biomarker Diagnostic Platforms: This trend involves developing integrated systems that can measure not only tear osmolarity but also other key biomarkers of dry eye disease, such as inflammatory markers like MMP-9. The impact is a more comprehensive diagnostic picture. This provides clinicians with a more complete understanding of a patient's condition, enabling a more targeted and effective treatment strategy.

These trends are collectively reshaping the market by transforming tear osmolarity systems from a specialized diagnostic tool into an integrated, efficient, and data-driven component of routine eye care. The focus has shifted to a holistic approach that prioritizes diagnostic accuracy, user convenience, and the seamless integration of technology into the clinical workflow.

Recent Developments in the Tear Osmolarity System Market

The tear osmolarity system market is being impacted by a series of recent developments that are significantly influencing product design, functionality, and market reach. These advancements are driven by a combination of technological innovation, evolving patient needs, and a greater emphasis on objective diagnostic tools. These developments are making systems more effective, accessible, and user-friendly.

• Introduction of Handheld and Portable Devices: The commercial launch of smaller, handheld tear osmolarity systems has been a key development. This allows for testing to be conducted in a wider range of clinical settings, including small optometry practices. The impact is a significant increase in the accessibility of this diagnostic tool, moving it from specialized clinics to the point-of-care.
• Advancements in Microfluidic Technology: Recent developments in microfluidic technology have allowed for the collection and analysis of a minimal tear sample (less than 100 nanoliters). This makes the test less invasive and more comfortable for patients. The impact is a major improvement in the patient experience, which is crucial for encouraging wider adoption of the diagnostic test.
• FDA Clearance for New Systems: The U.S. market has seen recent FDA clearances for new tear osmolarity systems. This regulatory approval provides a strong signal of trust and safety to healthcare providers. The impact is an acceleration of market adoption and a boost in confidence among ophthalmologists and optometrists regarding the clinical utility of the device.
• Use of Impedance Spectroscopy: Many of the new systems are using impedance spectroscopy to measure tear osmolarity. This method is highly accurate and provides rapid results. The impact is a more reliable and efficient diagnostic process. The quantitative, objective data from these systems helps to remove the subjectivity often associated with traditional dry eye tests.
• Strategic Partnerships and Acquisitions: The market is witnessing a trend of major medical device companies forming strategic partnerships with or acquiring smaller, innovative startups. This consolidation allows market leaders to quickly integrate new technologies and expand their product portfolios. The impact is a faster path to market for innovative products and a more concentrated, competitive landscape.

These developments are collectively impacting the market by fostering a shift towards a more patient-centric and technology-driven approach to dry eye diagnosis. They are not only improving the quality of the diagnostic data but are also making the process more convenient, accessible, and integrated into modern clinical practice.

Strategic Growth Opportunities in the Tear Osmolarity System Market

The tear osmolarity system market is presenting significant strategic growth opportunities across key applications, driven by the increasing awareness of DED and the need for objective diagnosis. By targeting these specific applications, companies can expand their market presence and cater to the unique needs of different user segments, from high-volume clinics to research institutions.

• Ophthalmology and Optometry Clinics: This is the largest and most significant growth opportunity. As more ophthalmologists and optometrists recognize tear osmolarity as a "gold standard" for DED diagnosis, the demand for systems in their clinics is soaring. The impact is a focus on developing user-friendly, portable, and reliable systems that can seamlessly integrate into a busy practice.
• Hospitals and Surgical Centers: This application presents a major growth opportunity as hospitals use tear osmolarity to screen patients for DED before cataract and refractive surgeries. Undiagnosed DED can negatively impact surgical outcomes. The impact is a focus on providing high-quality, reliable systems for a high-volume, pre-operative screening environment.
• Clinical Research: This application is a niche but high-growth opportunity. Tear osmolarity systems are crucial for clinical trials of new dry eye therapies, as they provide an objective endpoint for measuring treatment efficacy. The impact is a focus on developing highly accurate, validated systems for a specialized market segment that requires a strong emphasis on data integrity.
• Home-based Monitoring: The trend of home-based care presents a major growth opportunity. The market can grow by providing user-friendly systems for patients to monitor their tear osmolarity at home. The impact is a shift from clinical to consumer-driven products, leading to a broader consumer base and a focus on convenience, privacy, and ease of use.
• Emerging Economies: The markets in China, India, and other emerging economies represent a major growth opportunity. The focus is on providing cost-effective and high-quality tear osmolarity systems to meet the rising demand for eye care. The impact is a long-term growth strategy that requires a strong focus on local manufacturing, accessible pricing, and building a local distribution network.

These opportunities are impacting the market by encouraging diversification and specialization. Companies are now able to create products and services that cater to the unique needs of different applications, leading to a more segmented and competitive market that is better equipped to serve the distinct needs of a wide range of patients and healthcare providers.

Tear Osmolarity System Market Driver and Challenges

The tear osmolarity system market is influenced by a combination of key drivers and challenges, which include various technological, economic, and regulatory factors. Understanding these forces is essential for market players to develop effective strategies and maintain a competitive edge. The market's trajectory is shaped by factors that both foster growth and create significant obstacles.

The factors responsible for driving the tear osmolarity system market include:

1. Increasing Prevalence of Dry Eye Disease: The rising global incidence of DED, linked to factors like aging, increased screen time, and environmental pollution, is a primary driver. This creates a large and expanding patient pool requiring objective diagnostic tools. This trend provides a consistent and robust demand for tear osmolarity systems.

2. Growing Preference for Objective Diagnostics: Healthcare professionals are increasingly moving away from subjective diagnostic methods like patient questionnaires and towards objective biomarkers for DED. Tear osmolarity provides a quantitative, reproducible measure of tear film health. This driver is pushing for greater adoption of these systems as the "gold standard" for diagnosis.

3. Rising Healthcare Expenditure: The increase in healthcare spending, particularly in emerging economies, is a key driver. As more individuals gain access to insurance and advanced medical care, the demand for sophisticated diagnostic tools rises. This economic trend makes expensive, innovative systems more accessible to a wider patient population.

4. Technological Advancements in Systems: The development of lighter, more portable, and feature-rich systems is a major driver. Innovations like handheld designs, faster test times, and smaller sample volume requirements make products more appealing. This technological evolution enhances user convenience and facilitates seamless integration into clinical workflows.

5. Growing Geriatric Population: The global increase in the elderly population is a key driver. As people age, their susceptibility to DED increases. This demographic shift provides a large and stable customer base, fueling a consistent demand for systems that enable early diagnosis and effective long-term management of chronic dry eye.

Challenges in the tear osmolarity system market are:

1. High Cost of Devices: The initial acquisition cost of tear osmolarity systems, as well as the ongoing cost of disposable test cards, is a significant challenge. This can be a barrier to adoption, especially for smaller clinics or practices in developing countries with limited budgets and without robust reimbursement.

2. Lack of Standardized Diagnostic Protocols: Despite tear osmolarity being a key marker, there is still a lack of a single, universally accepted diagnostic protocol for DED. This can lead to variations in how the test is used and interpreted, creating confusion for clinicians and potentially limiting widespread adoption as a standalone test.

3. Competition from Traditional Tests: The market faces strong competition from traditional, less expensive dry eye diagnostic tests like the Schirmer's test and tear break-up time (TBUT) measurements. While less objective, these tests are well-established and widely available. This competition forces tear osmolarity system manufacturers to continuously demonstrate the clinical superiority of their products.

The overall impact of these drivers and challenges is a market that is dynamic and highly competitive. While powerful drivers like a rising DED prevalence and a preference for objective data are propelling growth, significant challenges related to cost, standardization, and competition are creating a more deliberate adoption cycle. Successfully addressing these challenges will be key for future market leaders.

List of Tear Osmolarity System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tear osmolarity system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tear osmolarity system companies profiled in this report include-

• I-MED Pharma
• Trukera Medical
• TearLab Corporation
• AbbVie

Tear Osmolarity System Market by Segment

The study includes a forecast for the global tear osmolarity system market by type, application, and region.

Tear Osmolarity System Market by Type [Value from 2019 to 2031]:

• Handheld
• Desktop

Tear Osmolarity System Market by Application [Value from 2019 to 2031]:

• Hospitals
• Ophthalmology Clinics
• Others

Country Wise Outlook for the Tear Osmolarity System Market

Recent developments in the tear osmolarity system market are fueled by the rising prevalence of dry eye disease and the demand for objective, quantitative diagnostic tools. Innovations are focusing on creating more portable, user-friendly, and accurate devices that provide real-time data. The market is also being reshaped by a growing awareness among healthcare professionals and patients about the importance of early and precise DED diagnosis for effective management.

• United States: The U.S. market is a leader in product innovation, driven by a high volume of DED patients and a well-established healthcare infrastructure. Recent developments include FDA clearance for new portable, handheld systems that offer faster and more efficient testing at the point of care. Favorable reimbursement policies also continue to support the adoption of advanced diagnostic tools.
• China: The Chinese market is experiencing rapid growth, driven by an expanding middle class, rising healthcare expenditure, and a large population with increasing screen time. Recent developments are focused on domestic production of affordable tear osmolarity systems to meet the high demand. There is also a growing emphasis on educating healthcare professionals about the value of objective DED diagnosis.
• Germany: Germany's market is characterized by a strong emphasis on high-quality, precision-engineered medical devices. Key developments include a push for systems with advanced data analytics and integration with electronic health records (EHR). The market is also seeing an increase in R&D for more advanced, non-invasive systems that provide superior accuracy and reliability.
• India: The Indian market is witnessing significant growth, fueled by a large patient pool and improving eye care infrastructure. A key development is the rising demand for affordable diagnostic devices. There is a focus on local manufacturing to reduce costs and make tear osmolarity testing more accessible in a wide range of clinics, including in semi-urban areas.
• Japan: The Japanese market is distinguished by its high adoption of sophisticated medical technologies and a rapidly aging population. Recent developments include the use of miniaturization and advanced materials to create highly portable and easy-to-use systems. The market is also seeing a strong demand for products that are compatible with telemedicine, reflecting a national focus on aging in place and remote patient care.

Features of the Global Tear Osmolarity System Market

• Market Size Estimates: Tear osmolarity system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Tear osmolarity system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Tear osmolarity system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the tear osmolarity system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tear osmolarity system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the tear osmolarity system market by type (handheld and desktop), application (hospitals, ophthalmology clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Tear Osmolarity System Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Handheld: Trends and Forecast (2019-2031)
• 4.4 Desktop: Trends and Forecast (2019-2031)

5. Global Tear Osmolarity System Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospitals: Trends and Forecast (2019-2031)
• 5.4 Ophthalmology Clinics: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Tear Osmolarity System Market by Region

7. North American Tear Osmolarity System Market

• 7.1 Overview
• 7.2 North American Tear Osmolarity System Market by Type
• 7.3 North American Tear Osmolarity System Market by Application
• 7.4 United States Tear Osmolarity System Market
• 7.5 Mexican Tear Osmolarity System Market
• 7.6 Canadian Tear Osmolarity System Market

8. European Tear Osmolarity System Market

• 8.1 Overview
• 8.2 European Tear Osmolarity System Market by Type
• 8.3 European Tear Osmolarity System Market by Application
• 8.4 German Tear Osmolarity System Market
• 8.5 French Tear Osmolarity System Market
• 8.6 Spanish Tear Osmolarity System Market
• 8.7 Italian Tear Osmolarity System Market
• 8.8 United Kingdom Tear Osmolarity System Market

9. APAC Tear Osmolarity System Market

• 9.1 Overview
• 9.2 APAC Tear Osmolarity System Market by Type
• 9.3 APAC Tear Osmolarity System Market by Application
• 9.4 Japanese Tear Osmolarity System Market
• 9.5 Indian Tear Osmolarity System Market
• 9.6 Chinese Tear Osmolarity System Market
• 9.7 South Korean Tear Osmolarity System Market
• 9.8 Indonesian Tear Osmolarity System Market

10. ROW Tear Osmolarity System Market

• 10.1 Overview
• 10.2 ROW Tear Osmolarity System Market by Type
• 10.3 ROW Tear Osmolarity System Market by Application
• 10.4 Middle Eastern Tear Osmolarity System Market
• 10.5 South American Tear Osmolarity System Market
• 10.6 African Tear Osmolarity System Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Tear Osmolarity System Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 I-MED Pharma
  • Company Overview
  • Tear Osmolarity System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Trukera Medical
  • Company Overview
  • Tear Osmolarity System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 TearLab Corporation
  • Company Overview
  • Tear Osmolarity System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 AbbVie
  • Company Overview
  • Tear Osmolarity System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us